2010

1. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

   Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465